Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Adenosine A(3) receptor-induced proliferation of primary human coronary smooth muscle cells involving the induction of early growth response genes.

Hinze AV, Mayer P, Harst A, von Kügelgen I.

J Mol Cell Cardiol. 2012 Nov;53(5):639-45. doi: 10.1016/j.yjmcc.2012.08.003. Epub 2012 Aug 12.

PMID:
22906537
2.

Investigational A₃ adenosine receptor targeting agents.

Koscsó B, Csóka B, Pacher P, Haskó G.

Expert Opin Investig Drugs. 2011 Jun;20(6):757-68. doi: 10.1517/13543784.2011.573785. Epub 2011 Apr 2. Review.

3.

Adenosine receptors as potential targets in melanoma.

Montinaro A, Iannone R, Pinto A, Morello S.

Pharmacol Res. 2013 Oct;76:34-40. doi: 10.1016/j.phrs.2013.07.002. Epub 2013 Jul 13. Review.

PMID:
23856527
4.

A(3) adenosine receptor: a plausible therapeutic target for cardio-protection in diabetes.

Nishat S, Shabir H, Azmi AS, Ansari HR.

Recent Pat Cardiovasc Drug Discov. 2012 Apr;7(1):59-70. Review.

PMID:
22300387
5.

Structural Probing and Molecular Modeling of the A₃ Adenosine Receptor: A Focus on Agonist Binding.

Ciancetta A, Jacobson KA.

Molecules. 2017 Mar 11;22(3). pii: E449. doi: 10.3390/molecules22030449. Review.

6.

[Progress of study on inhibitory effects of traditional Chinese herbs on growth factor induced proliferation of vascular smooth muscle cells].

Yang G, Zhang MZ, Jiang W.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005 Oct;25(10):951-4. Review. Chinese.

PMID:
16313125
7.

The A3 adenosine receptor: history and perspectives.

Borea PA, Varani K, Vincenzi F, Baraldi PG, Tabrizi MA, Merighi S, Gessi S.

Pharmacol Rev. 2015;67(1):74-102. doi: 10.1124/pr.113.008540. Review.

8.

Adenosine A3 Receptor: A promising therapeutic target in cardiovascular disease.

Nishat S, Khan LA, Ansari ZM, Basir SF.

Curr Cardiol Rev. 2016;12(1):18-26. Review.

9.

A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy.

Jacobson KA, Merighi S, Varani K, Borea PA, Baraldi S, Aghazadeh Tabrizi M, Romagnoli R, Baraldi PG, Ciancetta A, Tosh DK, Gao ZG, Gessi S.

Med Res Rev. 2017 Jul 6. doi: 10.1002/med.21456. [Epub ahead of print] Review.

PMID:
28682469
10.

Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics.

Janes K, Symons-Liguori AM, Jacobson KA, Salvemini D.

Br J Pharmacol. 2016 Apr;173(8):1253-67. doi: 10.1111/bph.13446. Epub 2016 Mar 6. Review.

11.

Early growth response 2 and Egr3 are unique regulators in immune system.

Taefehshokr S, Key YA, Khakpour M, Dadebighlu P, Oveisi A.

Cent Eur J Immunol. 2017;42(2):205-209. doi: 10.5114/ceji.2017.69363. Epub 2017 Aug 8. Review.

12.

Early growth response-1 in the pathogenesis of cardiovascular disease.

Khachigian LM.

J Mol Med (Berl). 2016 Jul;94(7):747-53. doi: 10.1007/s00109-016-1428-x. Epub 2016 Jun 1. Review.

PMID:
27251707

Supplemental Content

Support Center